logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • Cookie opt-out
  • Cookie opt-out
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Samples
    2. /
    3. Pradaxa
    Cardiovascular

    Pradaxa Samples

    dabigatran etexilate

    Manufacturer
    Boehringer Ingelheim
    Indication
    Direct thrombin inhibitor anticoagulant

    How It Works

    1
    Enter your NPI number and email address
    2
    We check your eligibility with Boehringer Ingelheim
    3
    Order samples instantly or request access
    Free for healthcare providers
    350K+ providers use PrescriberPoint

    Pradaxa Sample FAQs

    Are Pradaxa samples available for healthcare providers?

    Pradaxa samples may be available through Boehringer Ingelheim's patient access programs. Check your eligibility on PrescriberPoint by entering your NPI number to see current availability.

    How do I get free Pradaxa samples?

    To request free Pradaxa (dabigatran etexilate) samples, enter your NPI number on PrescriberPoint. We'll instantly verify your eligibility with Boehringer Ingelheim and show you how to order samples. The process takes less than a minute and is completely free for licensed prescribers.

    Who is eligible for Pradaxa drug samples?

    Licensed healthcare providers including physicians (MDs, DOs), nurse practitioners, and physician assistants with valid NPI numbers may be eligible for Pradaxa samples. Eligibility is determined by Boehringer Ingelheim based on your prescribing credentials and state licensing. PrescriberPoint checks your eligibility instantly.

    How long does it take to receive Pradaxa samples?

    Delivery times for Pradaxa samples from Boehringer Ingelheim typically range from 2-4 weeks after your request is approved. Some manufacturers offer expedited shipping. You'll receive confirmation once your samples are processed.

    More from Boehringer Ingelheim

    View all
    Spiriva
    tiotropium bromide
    Respiratory
    Ofev
    nintedanib
    Pulmonology
    Tradjenta
    linagliptin
    Diabetes

    More Cardiovascular Samples

    View all
    Eliquis
    apixaban
    Pfizer
    Xarelto
    rivaroxaban
    Janssen (J&J)
    Entresto
    sacubitril/valsartan
    Novartis
    Repatha
    evolocumab
    Amgen
    Brilinta
    ticagrelor
    AstraZeneca
    Leqvio
    inclisiran
    Novartis

    Popular Samples

    Browse all
    Ozempic
    semaglutide injection
    Novo Nordisk
    Diabetes
    Keytruda
    pembrolizumab
    Merck
    Oncology
    Dupixent
    dupilumab
    Sanofi
    Immunology
    Eylea
    aflibercept
    Regeneron
    Ophthalmology
    105+
    Products Available
    50+
    Manufacturers
    20+
    Therapeutic Areas